NDAORALTABLET
Approved
Sep 1980
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
4/8 — Partial
ANAPROX (naproxen sodium) by Humanwell Pharmaceutical is mechanism of action naproxen has analgesic, anti-inflammatory, and antipyretic properties. Approved for migraine, pain, postoperative pain and 4 more indications. First approved in 1980.
Drug data last refreshed 20h ago
Mechanism of Action
Mechanism of Action Naproxen has analgesic, anti-inflammatory, and antipyretic properties. The sodium salt of naproxen has been developed as a more rapidly absorbed formulation of naproxen for use as an analgesic. The mechanism of action of the naproxen, like that of other NSAIDs, is not completely…
Worked on ANAPROX at Humanwell Pharmaceutical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.